The cell therapy industry is actively working to simplify and close processes to optimize manufacturing, reduce costs, and increase speeds of getting treatments to patients. While viral gene delivery has been in use for quite some time, nonviral delivery methods are attractive because of their reduced cytotoxicity, immunogenicit